小檗碱在甲状腺相关眼病中的潜在治疗活性:对眼眶成纤维细胞组织重塑的抑制作用
本研究在体外培养的控制组供者(n=6)和甲状腺相关眼病(TAO)患者(n=6)眼眶成纤维细胞中评估小檗碱(BBR)的效果。结果显示BBR剂量依赖性减少细胞内脂质积累并下调脂肪生成标志物,还抑制IL-1β诱导的促炎分子表达和TGF-β介导的透明质酸产生及纤维化。作者认为BBR在眼眶成纤维细胞中具有控制脂肪生成、炎症、透明质酸产生和纤维化的能力,提示其在TAO管理中的潜在治疗作用。
要点
- 小檗碱剂量依赖性减少TAO眼眶成纤维细胞内的脂质积累并下调脂肪生成标志物。
- 小檗碱通过阻断核因子-κB信号通路抑制IL-1β诱导的促炎分子表达。
- 小檗碱抑制TGF-β介导的透明质酸产生和纤维化,提示潜在治疗作用。
核心结论
- 小檗碱在眼眶成纤维细胞中具有控制脂肪生成、炎症、透明质酸产生和纤维化的能力,提示其在TAO管理中的潜在治疗作用。
研究设计与样本
- 体外研究,取控制组供者(n=6)和TAO患者(n=6)的眼眶成纤维细胞进行培养。
主要发现
- TAO眼眶成纤维细胞而非控制组成纤维细胞在商业培养基中易分化为脂肪细胞。
- 小檗碱剂量依赖性减少细胞内脂质积累,并下调脂肪生成标志物。
- RNA测序筛选出PPARγ和AMPK通路,小檗碱抑制其下游效应物。
- 小檗碱通过阻断核因子-κB信号通路减弱IL-1β诱导的促炎分子表达,在TAO组和控制组成纤维细胞中均如此。
- 小檗碱对TGF-β介导的组织重塑的抑制作用在眼眶成纤维细胞中得到证实。
关键数值与推荐
- CCK-8法用于评估最佳浓度范围。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Berberine (BBR), an alkaloid produced by a traditional Chinese plant, was recently attributed multiple effects on lipometabolism, inflammation, and fibrosis. Thyroid-associated ophthalmopathy (TAO) is highly associated with these pathologic changes. Thus, we aimed to examine the potential therapeutic effect of BBR in an in vitro model of TAO. METHODS: Orbital fibroblasts (OFs) obtained from control donors (n = 6) or patients with TAO (n = 6) were cultured. The CCK-8 assay was conducted for assessing the optimal concentration range. Oil Red O staining, Western blotting, and quantitative RT-PCR (qRT-PCR) were conducted to assess adipogenesis in OFs. RNA sequencing (RNA-seq) was used to screen the key pathways of the antiadipogenic effect mediated by BBR. Along with incremental concentrations of BBR, IL-1β-induced expression of proinflammatory molecules was determined by ELISA and qRT-PCR. In addition, TGF-β-induced hyaluronan (HA) production and fibrosis were evaluated by ELISA, qRT-PCR, and Western blotting. RESULTS: TAO-OFs, but not control fibroblasts (CON-OFs), were readily differentiated into adipocytes with the commercial medium. Intracellular lipid accumulation was dose-dependently decreased by BBR, and adipogenic markers were also downregulated. Moreover, the PPARγ and AMPK pathways were screened out by RNA-seq and their downstream effectors were suppressed by BBR. Besides, BBR attenuated IL-1β-induced expression of proinflammatory molecules in both TAO-OFs and CON-OFs by blocking nuclear factor-κB signaling. BBR's inhibitory effect on TGF-β-mediated tissue remodeling was also confirmed in OFs. CONCLUSIONS: These findings demonstrate BBR has outstanding capabilities of controlling adipogenesis, inflammation, HA production, and fibrosis in OFs, highlighting its potential therapeutic role in TAO management.
引用
- Diao J, Chen X, Mou P, et al. Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts. Invest Ophthalmol Vis Sci. 2022. PMID: 36094643. doi:10.1167/iovs.63.10.6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。